Why the study?
Mitral regurgitation is a serious post-myocardial infarction complication with increasing mortality, and primary surgical treatment carries a high risk.
Does MitraClip improve clinical outcomes in a patient with severe post-myocardial infarction mitral regurgitation?
Does MitraClip improve clinical outcomes in a patient with severe post-myocardial infarction mitral regurgitation?
Answers are grounded in this paper and cite their sources.
MitraClip may serve as a safe and effective therapeutic strategy for patients with severe post-myocardial infarction mitral regurgitation who are at high surgical risk.
Mitral regurgitation is a serious complication of post-myocardial infarction, with increasing mortality. Surgery as the primary treatment carries a high risk. MitraClip is a new therapeutic to treat post-myocardial infarction mitral regurgitation. In this case, a 62-year-old male patient suffered from severe heart failure symptoms after emergency coronary intervention and extracorporeal membrane oxygenation support. Based on cardiac echocardiography, severe mitral regurgitation was monitored in this patient. After MitraClip treatment, the patient's condition was gradually improved and discharged successfully. This case highlights that MitraClip is a safe and effective strategy for post-myocardial infarction mitral regurgitation.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: